Impact of anti-PCSK9 antibody Alirocumab on lipid-lowering on patient motivation to treatment for hypercholesterolemia.
Not Applicable
Recruiting
- Conditions
- Dyslipidemia Diabetes mellitus
- Registration Number
- JPRN-UMIN000029310
- Lead Sponsor
- Minamiosaka Hospital Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnant 2)Drug allergy to Alirocumab 3)Unsuitable patients for this study by physicians decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method